Bilateral central retinal vein occlusion associated with multiple myeloma

Ophthalmologica

Volumn 218, Issue 4, 2004, Pages 283-287

  Aggio, Fabio B ^a,c   Cariello, Angelino J ^a   Almeida, Manuella S S ^b   Rodrigues, Celso A ^b   De Moraes, Nilva S B ^a   Colleoni, Gisele W B ^b   Farah, Michel E ^a  

^a Departamento de Oftalmologia   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Alameda Jaú ^*  (Brazil)

Author keywords

Blood viscosity; Multiple myeloma; Retinal vein occlusion

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LABORATORY TEST; MEDICAL EXAMINATION; MEDLINE; MULTIPLE MYELOMA; OPHTHALMOLOGY; PRIMARY MEDICAL CARE; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DOXORUBICIN; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MULTIPLE MYELOMA; RETINAL NEOPLASMS; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VINCRISTINE;

EID: 3242749166     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078622     Document Type: Article

References (19)

1. Enzenauer RW, Brozetti JJ, Dragoo RA: Central retinal vein occlusion in a patient with IgG lambda monoclonal gammopathy. Arch Ophthalmol 1999;117:134-135.
2. Central Vein Occlusion Study Group: Baseline and early natural history report: The Central Vein Occlusion Study (commented on in Arch Ophthalmol 1993;113:555). Arch Ophthalmol 1993;111:1087-1095.
3. Segev F, Segev A, Livne A, Assia EI, Mekori YA: Bilateral central retinal vein occlusion in a patient with occult colon cancer. Arch Ophthalmol 2001;119:1552-1553.
4. Crawford J, Cox EB, Cohen HJ: Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 1985;79:13-22.
5. Friedman AH: Ocular manifestations of hematologic disorders. Hosp Pract 1984;19:131-139.
6. Durie BG: Staging and kinetics of multiple myeloma. Semin Oncol 1986;13:300-309.
7. Segeren CM, Sonneveld P, van der Holt B, Baars JW, Biesma DH, Cornellissen JJ, et al: Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol 1999;105:127-130.
8. Elman MJ, Bhatt AK, Quinlan PM, Enger C: The risk of systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990;97:1543-1548.
9. Hayasaka S, Ugomori S, Kodama T, Noda S, Setogawa T: Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity. Ann Ophthalmol 1993;25:191-194.
10. Chiang CC, Begley S, Henderson SO: Central retinal vein occlusion due to hyperviscosity syndrome. J Emerg Med 2000;18:23-26.
11. Bloch JK, Maki DG: Hyperviscosity syndromes associated with immunoglobulin abnormalities. Semin Hematol 1973;10:113-124.
12. Manegold PC, Hutter J, Pahernik SA, Messmer K, Dellian M: Platelet-endothelial interaction in tumor angiogenesis and microcirculation. Blood 2003;101:1970-1976.
13. Reinhart WH, Lutolf O, Nydegger UR, Mahler F, Straub PW: Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: Influence on blood rheology and the microcirculation. J Lab Clin Med 1992;119:69-76.
14. Patterson WP, Caldwell CW, Doll DC: Hyperviscosity syndrome and coagulopathies. Semin Oncol 1990;17:210-216.
15. Fahey JL, Barth WF, Solomon A: Serum hyperviscosity syndrome. JAMA 1965;192:120-123.
16. Euler HH, Schmitz N, Löffler H: Plasmapheresis in paraproteinemia. Blut 1985;50:321-330.
17. Orlin JB, Berkman EM: Partial plasma exchange using albumin replacement: Removal and recovery of normal plasma constituents. Blood 1980;56:1055-1059.
18. Wells R: Syndromes of hyperviscosity. N Engl J Med 1970;283:183-186.
19. Robert F, Mignucci M, McCurdy SA, Maldonado N, Lee JY: Hemostatic abnormalities associated with monoclonal gammopathies. Am J Med Sci 1993;306:359-366.